Likes 0Comments 0
Business · Multiply Labs · 2026-10-06
Multiply Labs raises $75 million for robotic biomanufacturing
Three key points
- Multiply Labs raised a reported $75 million Series B led by NantWorks, with AstraZeneca and Teradyne among the participants.
- It automates repetitive steps in biological drug manufacturing.
- A 74% cost-per-dose reduction and up to 100-fold throughput are company claims, not universal validated outcomes.
Story summary
Multiply Labs raised a reported $75 million Series B led by NantWorks, with AstraZeneca and Teradyne among the participants. It automates repetitive steps in biological drug manufacturing. A 74% cost-per-dose reduction and up to 100-fold throughput are company claims, not universal validated outcomes.
Login required. Log in to recommend stories and write comments.
Comments 0
Be the first to comment.